Zydus Cadila will get USFDA nod to market generic HIV an infection therapy tablets, Well being Information, ET HealthWorld

Drug agency Zydus Cadila on Friday stated it has acquired approval from the US well being regulator to market generic Emtricitabine and Tenofovir Disoproxil Fumarate tablets used for therapy of HIV infection. The corporate has acquired remaining approval from the United States Food and Drug Administration (USFDA) to market Emtricitabine and Tenofovir Disoproxil Fumarate tablets, 100 mg/150 mg, 133 mg/200 mg and 167 mg/250 mg, Zydus Cadila stated in an announcement.

The drug might be manufactured on the group’s formulation manufacturing facility at SEZ, Ahmedabad, it added.

The drug is used with different HIV drugs to assist management HIV an infection. It helps to lower the quantity of HIV in a single’s physique in order that the immune system can work higher, Zydus Cadila stated.

The group now has 319 approvals and has thus far filed over 400 abbreviated new drug applications (ANDAs) because the graduation of its submitting course of, it added.

Shares of Cadila Healthcare, the listed entity of Zydus group had been buying and selling at Rs 639.95 per scrip on BSE, up 0.18 per cent from its earlier shut.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *